Immix Biopharma, Inc. IMMX
10.97
(0.73)
(6.24%)
as of 25 Sep
- Market cap
- $844.3M
- P/E
- 0.0×
Follow IMMX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.53 | 10.01 | 8.76 | 25.13 |
Net Debt/EBITDA |
2.12 | 9.29 | 8.49 | 18.83 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 1.03 | 0.97 | 1.02 | |
Capex/Depreciation |
(2.76) | (1.82) | (0.25) | (0.16) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.20) | (0.34) | (0.18) | (0.18) | |
Cash per Share |
0.50 | 3.05 | 1.64 | 3.64 | |
Shareholders Equity per Share |
0.26 | 2.85 | 1.52 | 3.59 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.26 | 2.85 | 1.52 | 3.59 | |
Free Cash Flow |
(6.28) | (11.19) | (9.86) | (11.76) | |
Working Capital |
5.73 | 91.13 | 81.74 | 224.49 | |
Capital Expenditures |
(0.37) | (0.17) | (0.03) | (0.02) | |
Net Current Asset Value |
4.77 | 90.19 | 80.82 | 223.60 | |
| Other line items | |||||
Quick Ratio |
1.47 | 9.93 | 8.59 | 24.95 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.18) | (0.33) | (0.18) | (0.18) | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Average Payables |
8.61 | 9.30 | 9.83 | 9.56 | |
Average Assets |
22.61 | 63.89 | 57.85 | 127.37 | |
Average Common Equity |
12.91 | 53.52 | 46.98 | 116.78 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates